Balansag, Rodelia B.
HRN: 08-69-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/23/2023
10/29/2023
IV
2.25gm
Q8
Septicemia
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes